PHARMACOKINETICS OF PHENOPERIDINE
نویسندگان
چکیده
منابع مشابه
Elimination of phenoperidine in liver disease.
The disposition and elimination of phenoperidine was studied in five normal subjects, and in six patients with hepatic disease. Plasma concentrations of phenoperidine were generally higher in patients with hepatic dysfunction. Secondary peaks were observed between 15 and 105 min (particularly in patients with liver disease). In the patients the terminal half-life of phenoperidine was prolonged ...
متن کاملPlasma concentration and metabolism of phenoperidine in man.
The plasma concentrations of phenoperidine were measured in five patients during general anaesthesia. The concentration of the drug decreased rapidly between 2 and 40 min and then declined more slowly. Detectable concentrations of phenoperidine were present in plasma for at least 3 h. In the five patients, the distribution half-life of the drug ranged from 3.19 to 14.23 min and the elimination ...
متن کاملClinical and circulatory effects of neuroleptanalgesia with dehydrobenzperidol and phenoperidine.
The majority of cardiovascular laboratories concerned with diagnostic investigations routinely employ a variety of analgesic and sedative drugs during intravascular procedures. There is little doubt that many of these drugs have significant PHARMACOLOGY Dehydrobenzperidol. This drug, marketed under the trade name of droperidol, is one of the butyrophenone series of neuroleptic drugs with the co...
متن کاملInfluence of bolus doses of phenoperidine on intracranial pressure and systemic arterial pressure in traumatic coma.
The effects of bolus doses of phenoperidine 1-2 mg i.v. either alone, or combined with pancuronium 2-4 mg, were investigated in seven patients in traumatic coma. Phenoperidine alone significantly reduced mean arterial pressure (MAP) by a mean (+/- SEM) of 13.2 (+/- 2.8) mm Hg. Overall there was no significant change in intracranial pressure (ICP) despite the decreases in MAP and, consequently, ...
متن کاملClinical Pharmacokinetics of Amikacin in Neonates
Amikacin is a bactericidal aminoglycoside. Aminoglycosides inhibit bacterial protein synthesis. The antibacterial spectrum of amikacin is the broadest of aminoglycosides. Because of its resistance to many of the aminoglycosides-inactivating enzymes, it has a special role in hospitals where gentamicin- and tobramycin-resistant microorganisms are prevalent. Amikacin is active against the majority...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Anaesthesia
سال: 1986
ISSN: 0007-0912
DOI: 10.1093/bja/58.7.821